Product Name | MF | CAS | Details |
---|
Autophagy-IN-2 | C17H19N5O | 2755454-90-9 | Details |
HDAC6-IN-6 | C20H15N3O2 | 2413603-10-6 | Details |
Resomelagon | C14H14N6O2 | 1809420-71-0 | Details |
HPGDS inhibitor 3 | C21H27N3O2 | 2255311-93-2 | Details |
SSAO inhibitor-2 | C14H21FN4O2 | 2671028-06-9 | Details |
NS2B/NS3-IN-3 | C19H21N3O2 | 2832876-90-9 | Details |
Dichlorphenamide disodium | C6H6Cl2N2Na2O4S2** | 76382-13-3 | Details |
RSV-IN-4 | C18H18N2O2S | 862825-89-6 | Details |
THK-5470 | C18H17FN2O2 | 2410554-04-8 | Details |
DK1 | C16H13ClN2O2 | 1187568-17-7 | Details |
Piperilate | C21H25NO3 | 4546-39-8 | Details |
Tubulin inhibitor 26 | C17H19N3O3 | 2379241-70-8 | Details |
SJ000063181 | C14H14ClFN2O2 | 945189-68-4 | Details |
Tubulin inhibitor 20 | C19H18O4 | 860356-56-5 | Details |
Peldesine dihydrochloride | C12H12ClN5O | 2772702-10-8 | Details |
PIN1 inhibitor 2 | C16H21N3S2 | 2417101-28-9 | Details |
HN37 | C20H21FN2O2 | 1821222-10-9 | Details |
Dyrk1A-IN-4 | C14H13F3N6 | 2091883-59-7 | Details |
Topoisomerase I inhibitor 2 | C18H15NO3 | 2588211-44-1 | Details |
HIV-1 inhibitor-36 | C14H14Cl2N2O2S | 2170506-18-8 | Details |
CB1R Allosteric modulator 2 | C19H15ClFN3O | 2513102-64-0 | Details |
Febuxostat sodium | C16H16N2NaO3S* | 1140907-13-6 | Details |
FC9402 | C19H16N4O | 2452401-65-7 | Details |
Viral 2C protein inhibitor 1 | C19H18FN3O | 1594427-18-5 | Details |
MIF-IN-1 | C15H13N3O5 | 851095-20-0 | Details |
NSC 107512 | C12H16N6O5 | 22242-89-3 | Details |
Monoacylglycerol lipase inhibitor 1 | C21H28N2O3 | 2714570-98-4 | Details |
PqsR/LasR-IN-3 | C14H17NO5S | 2581109-51-3 | Details |
DHDPS-IN-1 | C13H11NO5S | 1233344-34-7 | Details |
PF-06649298 | C16H22O5 | 1854061-16-7 | Details |
RUNX1/ETO tetramerization-IN-1 | C18H14O7 | 88755-39-9 | Details |
(Rac)-Upacicalcet | C11H14ClN3O6S | 2649575-19-7 | Details |
Ruzotolimod | C14H18N4O5S | 1948241-60-8 | Details |
LG308 | C19H17FN2O | 1428341-65-4 | Details |
Pirifibrate | C17H18ClNO4 | 55285-45-5 | Details |
ALDH1A3-IN-1 | C13H18BrNO | 1695970-90-1 | Details |
Tilomisole | C17H11ClN2O2S | 58433-11-7 | Details |
Chromenone 1 | C18H10F3N3O2 | 1639929-29-5 | Details |
VEGFR-2-IN-19 | C21H19N3O2 | 2456315-41-4 | Details |
Glyoxalase I inhibitor 5 | C16H14N4O3S | 2455508-17-3 | Details |
Pim-1 kinase inhibitor 1 | C19H13N3O3 | 2803505-57-7 | Details |
Tubulin polymerization-IN-15 | C18H17N3O4 | 2055517-66-1 | Details |
L82 | C11H8ClN5O4 | 329227-30-7 | Details |
SARM1-IN-2 | C16H14N4O2S | 2396592-52-0 | Details |
Metallo-β-lactamase-IN-5 | C19H16N4O3 | 1417737-65-5 | Details |
AMPK activator 2 | C13H18F3N5 | 2410961-69-0 | Details |
LasR-IN-4 | C18H20N4 | 183488-96-2 | Details |
TGFβRI-IN-5 | C16H12N2O6 | 2541690-15-5 | Details |
Topoisomerase I inhibitor 3 | C18H14FNO3 | 2588211-50-9 | Details |
GAL-021 sulfate | C11H24N6O5S | 1380342-00-6 | Details |
Netivudine | C12H14N2O6 | 84558-93-0 | Details |
BA38017 | C15H11ClFNO3 | 1333905-67-1 | Details |
TL8-506 | C20H17N3O2 | 1268163-15-0 | Details |
RSV-IN-3 | C16H12Cl2N2OS | 862825-90-9 | Details |
FPI-1465 | C11H18N4O7S | 1452458-70-6 | Details |
Simufilam hydrochloride | C15H22ClN3O | 2480226-07-9 | Details |
RSK2-IN-2 | C16H11N5O | 1637749-78-0 | Details |
DDO-02005 free base | C21H25N3O2 | 1186134-30-4 | Details |
ALK5-IN-8 | C19H15FN4O2 | 2705900-81-6 | Details |
Anticancer agent 46 | C15H14ClN3OS | 2426686-17-9 | Details |
MAO-B-IN-9 | C18H24N2O2 | 2416910-88-6 | Details |
Carbonic anhydrase inhibitor 2 | 2758231-43-3 | Details |
Exo2 | C18H18N4O2S | 304684-77-3 | Details |
CSV0C018875 | C18H17ClN2O | 442150-41-6 | Details |
PI5P4Ks-IN-1 | C20H17N3S | 959560-36-2 | Details |
Tropatepine | C22H23NS | 27574-24-9 | Details |
CYP1B1-IN-1 | C19H11ClO2 | 842122-33-2 | Details |
Type II topoisomerase inhibitor 1 | C18H15N3O4 | 2245691-60-3 | Details |
Sumatriptan hydrochloride | C14H22ClN3O2S | 103628-62-2 | Details |
GPR40 agonist 6 | C20H19NO4 | 1798751-25-3 | Details |
Metamizol | C13H17N3O4S | 50567-35-6 | Details |
FSG67 | C16H25NO4S | 1158383-34-6 | Details |
DDO-02001 | C20H24N2O2 | 1186049-49-9 | Details |
Topiramate lithium | C12H22LiNO8S | 488127-53-3 | Details |
Glyoxalase I inhibitor 7 | C17H16N4O3S | 2455508-31-1 | Details |
KDM4C-IN-1 | C14H13N5O3 | 52348-60-4 | Details |
NAAA-IN-1 | C18H17NO4 | 1439366-66-1 | Details |
MAO-B-IN-14 | C17H14O3S | 1904610-48-5 | Details |
Alpibectir | C12H14F6N2O2 | 2285440-39-1 | Details |
BRD9500 | C15H18FN3O2 | 1630760-75-6 | Details |
Steroid sulfatase-IN-2 | C17H22N2O4S | 2413880-39-2 | Details |
EP4 receptor antagonist 4 | C19H14N2OS | 691869-12-2 | Details |
MAO-B-IN-17 | C17H17F2NO2 | 2890188-81-3 | Details |
RSV/IAV-IN-2 | C19H20N2O3S | 2395007-75-5 | Details |
SSAO inhibitor-3 | C15H23FN4O3 | 2671028-09-2 | Details |
CaV1.3 antagonist-1 | C17H19ClN2O3 | 1391385-57-1 | Details |
Antimicrobial agent-2 | C16H14N2O4S | 2412592-33-5 | Details |
NHE3-IN-2 | C15H12ClN5 | 92434-13-4 | Details |
Topoisomerase II inhibitor 8 | C14H8N4O3S | 2493298-68-1 | Details |
RBP4 inhibitor 1 | C14H13F6NO3 | 1198180-03-8 | Details |
InhA-IN-3 | C14H12ClN3O2S | 900701-83-9 | Details |
HIF-1α-IN-3 | C19H17N5O2 | 2170715-64-5 | Details |
STAT3-IN-11 | C20H17NO4 | 2503096-50-0 | Details |
HDAC6-IN-9 | C19H16N2O3 | 2796282-58-9 | Details |
Oxaprozin potassium | C18H16KNO3 | 174064-08-5 | Details |
UCSF686 | C14H19N3O2S | 2248852-19-7 | Details |
Alinidine hydrobromide | C12H14BrCl2N3 | 71306-36-0 | Details |
TDO-IN-1 | C16H13F3N4O2 | 2490672-92-7 | Details |
SSAO/VAP-1 inhibitor 1 | C16H22ClFN2O3 | 2647975-06-0 | Details |
Globosuxanthone A | C15H12O7 | 917091-74-8 | Details |
Product Total: Product Page: | ||||
78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 |